Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin for cognitive deficits in children with Neurofibromatosis type 1
NL-OMON21351Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in neurofibromatosis type 1 (NF1) comparing Simvastatin with Placebo (2 arms). Primary endpoints: Visuospatial memory and attention performance, Movement adaptation neurophysiology and 1 more. Started Jan 2006; status: active, not recruiting.
02
Drugs
simvastatin
03
Conditions
neurofibromatosis type 1 (NF1)
Beyond the preview
Go deeper on NL-OMON21351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21351.